Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Rock Springs Capital Management LP(5.23%),Rock Springs Capital LLC(5.23%)
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Atlas Venture Fund XI, L.P.
Xilio Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OCTAGON CAPITAL ADVISORS LP(0%),OCTAGON INVESTMENTS MASTER FUND LP(0%), etc.
Xilio Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OCTAGON CAPITAL ADVISORS LP(6.48%),OCTAGON INVESTMENTS MASTER FUND LP(6.48%), etc.
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Atlas Venture Fund XI, L.P.
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Frankenfield Christopher James
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Luptakova Katarina
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brennan Kevin M.
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Russo Rene
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 10-Q: Quarterly report
Xilio Therapeutics | 8-K: Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
Xilio Therapeutics | 10-Q/A: Quarterly report (Amendment)
Xilio Therapeutics | 10-Q/A: Quarterly report (Amendment)
Xilio Therapeutics | 10-K/A: Annual report (Amendment)
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Luptakova Katarina
No Data